RE:RE:RE:RE:RE:RE:RE:RE:Not just BruceOmmm, good response. I ilke the fact you back your opinion with substance.
The reason why they got pushback was becaue the company was not a pure medical play. We are in agreement on this point. However, you are missing the point. They got pushback because they wanted to particpate in the recreational market. The recreational market is still not legal in Canada, that is why they got pushback from the exchange. You are missing the distinction. Aphria is only participating in the medical cannabis market in the United States becuase to particpate in recreational market would put them in violation of their TSX listing.
How can CannaRoyalty be listed on the TSXV when recreational is still not allowed legally in Canada. The CSE has more lax rules and that is why Marc Lusting chose to list on the CSE. That way he could particpate in the recreational market in the US and not be in violation of his CSE lsiting agreement.
Have you noticed how Aphria goes out of their way to always mention that they only particpate in the US medical market and not the recreational market. Aphria has only applied for medical licenses in the Untited Staes becuase to apply for a recreational license would put them offside with their TSX lsiting agreement.
Ommmmmm wrote: Alright, this article states:
"CEO Marc Lustig said he chose the CSE after pushback from the Toronto Stock Exchange because the company was not a pure medical play."
https://business.financialpost.com/commodities/agriculture/u-s-cannabis-company-gains-access-to-public-market-by-listing-on-canadian-stock-exchange/wcm/67a19737-1d57-47a5-96d8-c1fdb866ed89
So it was because they're not a pure medical play. I don't see how that's fair because just like Aphria they're operating only within legal states - why does it matter if it's legal medical or legal recreational? They're both still federally illegal in the U.S. anyway.
This article states:
"In the meantime, TMX appears to be taking a case-by-case approach to how it handles companies with U.S. interests. While Aphria is still listed even with its Florida investment, other producers have faced some push back.
No Consistent Answer
Canadian Bioceutical Corporation voluntarily delisted from the TSX Venture Exchange this year when the company was told it couldn’t pursue opportunities in the U.S. recreational market, said CEO Scott Boyes. The uncertainty has hampered the company’s efforts to partner with other larger Canadian firms, he said.
TMX hasn’t clearly explained its strategy and is depriving investors of a diversity of marijuana companies to choose from, said
CannaRoyalty Corp. CEO Marc Lustig. The Ottawa-based company has the bulk of its assets in the U.S. and is listed on the Canadian Securities Exchange. “They tell different companies different things about a policy, a made-up policy that doesn’t actually exist,” Lustig said by phone. “Nobody has an answer and nobody has a clear, consistent answer, which is a joke.”"
https://www.bloomberg.com/news/articles/2017-07-27/as-pot-craze-sweeps-canada-largest-exchange-debates-u-s-policy?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo
The second article said other producers have faced pushback. If Aphria is allowed to stay on the TSX then open the floodgates!
Monteviale wrote: Ommm....Can you please point out where it says the reasons CannaRoylaty was refused a listing on the TSX or TSXV.
Ommmmmm wrote: If APH stays then CRZ and others should be able to list on the TSX and TSXV.
Ommmmmm wrote:
CannaRoyalty wanted to list on the TSXV. CSE wasn't their first choice.
Monteviale wrote: Ommm...CannaRoyalty wasnt turned away. They decided themselves to list on the CSE. Marc Lusting was commenting on his perception of what the TMX policy is. At no time did he say they were refused.